Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Boron containing doai
Patent
1995-10-27
1998-07-14
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Boron containing doai
544229, C07F 502, C07F 504, A61K 3169
Patent
active
057804540
ABSTRACT:
Disclosed herein is a method for reducing the rate of degradation of proteins in an animal comprising contacting cells of the animal with certain boronic ester and acid compounds. Also disclosed herein are novel boronic ester and acid compounds, their synthesis and uses.
REFERENCES:
patent: 5550262 (1996-08-01), Iqbal et al.
patent: 5614649 (1997-03-01), Iqbal et al.
Bachovin, W.W., et al., "Nitrogen-15 NMR Spectroscopy of the Catalytic-Triad Histidine of a Serine Protease in peptide Boronic Acid Inhibitor Complexes," Biochemistry 27:7689-7697 (1988).
Berry, S.C., et al., "Interaction of Peptide Boronic Acids With Elastase: Circular Dichroism Studies," Proteins: Structure, Function, and Genetics 4:205-210 (1988).
Kettner, C.A., et al., "Kinetic Properties of the Binidng of .alpha.-Lytic Protease to Peptide Boronic Acids," Biochemistry 27:7682-7688 (1988).
Kinder, D.H., and Katzenellenbogen, J.A., "Acylamino Boronic Acids and Difluoroborane Analogues of Amino Acids: Potent Inhibitors of Chymotrypsin and Elastase," J. Med. Chem. 28:1917-1925 (1985).
Kinder, D.H., et al., "Antimetastatic Activity of Boro-Amino Acid Analog Protease Inhibitors against B16BL6 Melanoma in vivo," Invasion Metastasis 12:309-319 (1992).
Lim, M.S.L., et al., "The Solution Conformation of (D)Phe-Pro-Containing Peptides: Implications on the Activity of Ac-(D)Phe-Pro-boroArg-OH, a Potent Thrombinn Inhibitor," J. Med. Chem. 36(13): 1831-1838 (Jun. 25, 1993).
Matteson, D.S., et al., "(R)-1-Acetamido-2-phenylethaneboronic Acid. A Specific Transition-State Analogue for Chymotrypsin," J. Am. Chem. Soc. 103:5241-5242 (1981).
Takahashi, L.H., et al., "Crystallographic Analysis of the Inhibition of Porcine Pancreatic Elastase by a Peptidyl Boronic Acid: Structure of a Reaction Intermediate," Biochemistry 28:7610-7617 (1989).
Tsai, D.J.S., et al., "Diastereoselection in Reactions of Pinanediol Dichloromethaneboronate," Organometallics 2:1543-1545 (1983).
Tsilikounas, E., et al., "Identification of Serine and Histidine Adducts in Complexes of Trypsin and Trypsinogen with peptide and Nonpeptide Boronic Acid Inhibitors by .sup.1 H NMR Spectroscopy," Biochemistry 31:12839-12846 (1992).
Veale, C.A., et al., "Nonpeptidic Inhibitors of Human Leukocyte Elastase. 5. Design, Synthesis, and X-ray Crystallography of a Series of Orally Active 5-Aminpyrimidin-6-one-Containing Trifluoromethyl Ketones," J. Med. Chem. 38(1):98-108 (Jan. 6, 1995).
Adams Julian
Baevsky Matthew
Grenier Louis
Ma Yu-Ting
Plamondon Louis
ProScript, Inc.
Ramsuer Robert W.
LandOfFree
Boronic ester and acid compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Boronic ester and acid compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Boronic ester and acid compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1881875